Related references
Note: Only part of the references are listed.Combination effect of epsilon-poly-L-lysine and antibiotics against common bacterial pathogens
Sneha Sundaran et al.
JOURNAL OF ANTIBIOTICS (2022)
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
Kevin S. Ikuta et al.
LANCET (2022)
Artemisinin derivative DHA27 enhances the antibacterial effect of aminoglycosides against Pseudomonas aeruginosa by inhibiting mRNA expression of aminoglycoside-modifying enzymes
Nuoyan Wang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa
Haley J. Appaneal et al.
MICROBIOLOGY SPECTRUM (2022)
The membrane-active polyaminoisoprenyl compound NV716 re-sensitizes Pseudomonas aeruginosa to antibiotics and reduces bacterial virulence
Gang Wang et al.
COMMUNICATIONS BIOLOGY (2022)
Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
Giovanni Taccetti et al.
ANTIBIOTICS-BASEL (2021)
Antimicrobial Resistance in ESKAPE Pathogens
David M. P. De Oliveira et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
No money for new drugs
Benjamin Plackett
NATURE (2020)
A synthetic peptide sensitizes multi-drug resistantPseudomonas aeruginosato antibiotics for more than two hours and permeabilizes its envelope for twenty hours
Iosu Razquin-Olazaran et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Geographic and Temporal Patterns of Antimicrobial Resistance in Pseudomonas aeruginosa Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997-2016
Dee Shortridge et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Review of the application of epsilon-poly-L-lysine in improving food quality and preservation
Tuohetisayipu Tuersuntuoheti et al.
JOURNAL OF FOOD PROCESSING AND PRESERVATION (2019)
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Zheng Pang et al.
BIOTECHNOLOGY ADVANCES (2019)
Treatment of Pseudomonas aeruginosa Biofilm Present in Endotracheal Tubes by Poly-L-Lysine
Antoine Guillon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The bacterial outer membrane is an evolving antibiotic barrier
Kerrie L. May et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Bacterial Enzymes and Antibiotic Resistance
A. M. Egorov et al.
ACTA NATURAE (2018)
Effects of ε-Polylysine on Pseudomonas Aeruginosa and Aspergillus Fumigatus Biofilm In Vitro
Lianhua Wei et al.
MEDICAL SCIENCE MONITOR (2017)
Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa
Benjamin Davido et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis
Wynne D. Smith et al.
FEMS MICROBIOLOGY LETTERS (2017)
The characteristics of genetically related Pseudomonas aeruginosa from diverse sources and their interaction with human cell lines
Klrissa Streeter et al.
CANADIAN JOURNAL OF MICROBIOLOGY (2016)
Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options
Maitrayee Chatterjee et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Clinical applications of pulmonary delivery of antibiotics
Patrick A. Flume et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Poly-L-Lysine Compacts DNA, Kills Bacteria, and Improves Protease Inhibition in Cystic Fibrosis Sputum
Alice V. Dubois et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management
Francois Barbier et al.
CURRENT OPINION IN PULMONARY MEDICINE (2013)
Clinical relevance of the ESKAPE pathogens
Jack N. Pendleton et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Occurrence, Biosynthesis, Biodegradation, and Industrial and Medical Applications of a Naturally Occurring ε-Poly-L-lysine
Yoshimitsu Hamano
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2011)
Antibiotic treatment of CF lung disease: From bench to bedside
Robert Bals et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa
Audrey Bellemare et al.
BMC MICROBIOLOGY (2010)
Targeting mechanisms of Pseudomonas aeruginosa pathogenesis
E Kipnis et al.
MEDECINE ET MALADIES INFECTIEUSES (2006)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?
KA Brogden
NATURE REVIEWS MICROBIOLOGY (2005)
ε-Poly-L-lysine:: microbial production, biodegradation and application potential
T Yoshida et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2003)
Lung infections associated with cystic fibrosis
JB Lyczak et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Antibiotic synergy and antagonism
JF Acar
MEDICAL CLINICS OF NORTH AMERICA (2000)